Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy

Drugs
R C HeelG S Avery

Abstract

Captopril is the first orally active inhibitor of angiotensin-converting enzyme to become available. It has been studied primarily in hypertension. In mild to moderate essential hypertension captopril is about as effective as usual doses of hydrochlorothiazide or propranolol, about one-half of such patients needing the addition of a diuretic to achieve satisfactory control of blood pressure. In severe hypertension captopril plus a diuretic (and in some patients a beta-blocker) usually reduced blood pressure significantly more than could be achieved with 'standard triple therapy' in patients not responding adequately to such a regimen, and often resulted in an improved feeling of well-being in severely hypertensive patients previously receiving intensive multiple drug therapy. Indeed, at the present stage of the drug's development, patients not responding to or not tolerating 'traditional' antihypertensive therapy represent the most suitable candidates for captopril treatment. While captopril has been well tolerated in most patients, some troublesome or potentially serious side effects have been reported, including agranulocytosis, dysgeusia and reduced renal function; although a clear causal relationship with captopril was not ...Continue Reading

Citations

Jan 1, 1991·European Journal of Clinical Pharmacology·L Gonzalez-Sicilia de LlamasJ Hernandez Cascales
Jan 1, 1989·DICP : the Annals of Pharmacotherapy·L MalletJ Thomas
Jan 1, 1986·Medicinal Research Reviews·O H Drummer, B Jarrott
Dec 8, 1988·The New England Journal of Medicine·G H Williams
May 1, 1987·Angiology·A E BirbariS Mukaddam-Daher
Jan 1, 1986·British Journal of Clinical Pharmacology·B N Prichard, C W Owens
Apr 1, 1986·Journal of Clinical Pharmacology·W A CreaseyA A Sugerman
May 1, 1985·Journal of the Royal Society of Medicine·M S LaherT B Counihan
Jan 1, 1984·CRC Critical Reviews in Biochemistry·M A Ondetti, D W Cushman
Aug 1, 1984·Australian and New Zealand Journal of Medicine·C I Johnston
Apr 1, 1983·British Heart Journal·H J DargieJ I Robertson
Jan 1, 1984·British Journal of Clinical Pharmacology·C I JohnstonD Casley
Sep 1, 1983·Hypertension·J T GroelA C Jenkins
Jan 1, 1983·Clinical and Experimental Hypertension. Part A, Theory and Practice·K P OhmanS Wettre
Jan 1, 1982·Scandinavian Journal of Urology and Nephrology·M AurellH Mulec
Jan 1, 1982·British Journal of Clinical Pharmacology·J HavelkaH Vetter
Sep 25, 2014·Annual Review of Pharmacology and Toxicology·R D FeldmanS W Tobe
Mar 6, 2016·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Darren KlugmanJohn T Berger
Apr 1, 1986·Klinische Wochenschrift·P GremingerW Vetter
Feb 1, 1988·Drug Intelligence & Clinical Pharmacy·E A Jackson
Mar 1, 1982·British Heart Journal·K ChatterjeeW W Parmley
Oct 1, 1989·Journal of Clinical Pharmacy and Therapeutics·G G Skellern
Jun 13, 1987·British Medical Journal·D M Coulter, I R Edwards
Mar 1, 1989·British Journal of Clinical Pharmacology·M ChopraJ J Belch
Jan 1, 1983·European Journal of Clinical Pharmacology·J BiollazH R Brunner
Jan 1, 1983·Clinical and Experimental Hypertension. Part A, Theory and Practice·H R BrunnerJ Biollaz
Jan 1, 1983·Clinical and Experimental Hypertension. Part A, Theory and Practice·P LijnenA Amery
Jan 1, 1985·Clinical and Experimental Hypertension. Part A, Theory and Practice·A KnechtT Rosenthal
Sep 28, 1999·Journal of Cardiovascular Pharmacology·K Hayduk, H Kraul
Aug 3, 2004·Journal of Clinical Pharmacology·Steven G Chrysant, George S Chrysant

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.